Cardiff, UK – Diurnal Limited, a specialty pharmaceutical company dedicated to developing high-quality hormone therapeutics for patients with chronic endocrine diseases, has today announced the appointment of Alan Raymond as a non-executive director with immediate effect.
Dr Raymond has over 30 years of international marketing and general management experience within the pharmaceutical and biomedical industry, and most recently was the Sales and Marketing Director at Aesica Pharmaceuticals Ltd. During his career Alan has progressed through senior executive and marketing roles in Banner Pharmacaps, RP Scherer, Reckitt and Colman, Eli Lily and MSD, within the UK, Netherland and Australia. Prior to his industrial career, Alan was a postdoctoral researcher in the Cardiothoracic Research Institute (London) and he holds a PhD in invertebrate Neurobiology from St. Andrews University.
Alan is currently a Non-Executive Director with Oncimmune Ltd, a cancer diagnostics company.
Martin Whitaker, CEO of Diurnal, commented:
“We are very pleased to announce Alan’s appointment. Alan brings a wealth of industry experience and will be a great asset to the Board of Directors as we continue to implement the commercialisation strategy for our products.”
Please direct all enquiries to:
Martin Whitaker, CEO
+44 (0)871 716 8848
You are leaving http://www.diurnal.co.uk .Links to all outside websites are provided as a resource to our visitors. Outside websites are neither owned or controlled by Diurnal Ltd. Diurnal accepts no responsibility for the content of other websites.×